Trial
NCT00690118
Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
University of Ulm
Collaborators
—
Condition
Amyotrophic Lateral Sclerosis
Intervention
pioglitazone
Why stopped
The interim analysis showed no tendency in favour of the verum group. Therefore it was decided to stop the study prematurely.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-05-29